Speakers
Jamal Gasmi, MD, PhD
Vice President & Global Leader, Oncology and Hematology Drug Development, ICON Clinical Research, France
Gregory V Goldmacher, MD, PhD, MBA
Senior Director, Translational Biomarkers, Merck & Co. Inc., United States
Samuel C. Blackman, MD, PhD
Head of Clinical Development, Mavupharma, United States
James J. Conklin, MD, MS
Senior Vice President, Medical and Scientific Affairs, ICON Medical Imaging, United States
Have an account?